--- title: "首席商务官 Michael Chi 报告了出售 Hims & Hers Health Inc 普通股的情况" description: "Hims & Hers Health Inc. 的首席商务官 Michael Chi 报告了该公司普通股的处置。完整的文件可通过提供的链接获取。此消息由 Public Technologies 生成,仅供参考,不应被视为财务或法律建议。Hims & Hers Health Inc. 对于 2025 年 9 月 19 日通过 EDGAR 发布的原始内容负责" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/258571525.md" published_at: "2025-09-23T17:07:06.000Z" --- # 首席商务官 Michael Chi 报告了出售 Hims & Hers Health Inc 普通股的情况 > Hims & Hers Health Inc. 的首席商务官 Michael Chi 报告了该公司普通股的处置。完整的文件可通过提供的链接获取。此消息由 Public Technologies 生成,仅供参考,不应被视为财务或法律建议。Hims & Hers Health Inc. 对于 2025 年 9 月 19 日通过 EDGAR 发布的原始内容负责 Hims & Hers Health Inc. 的首席商务官 Michael Chi 报告了该公司普通股的处置。完整的文件可以通过以下链接访问。免责声明:本新闻简报由公共技术公司(PUBT)使用生成性人工智能创建。尽管 PUBT 努力提供准确和及时的信息,但此 AI 生成的内容仅供参考,不应被解读为财务、投资或法律建议。Hims & Hers Health Inc. 于 2025 年 9 月 19 日通过美国证券交易委员会(SEC)运营的电子数据收集、分析和检索系统 EDGAR 发布了用于生成本新闻简报的原始内容(参考 ID:0001773751-25-000312),并对此信息的内容承担全部责任。© 版权 2025 - 公共技术公司(PUBT)原始文件:这里 ### Related Stocks - [HIMS.US - Hims & Hers Health](https://longbridge.com/zh-CN/quote/HIMS.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Novo Nordisk reicht Patentanmeldung gegen Hims & Hers wegen Semaglutid-Produkten ein | Novo Nordisk A/S has filed a patent application for US Patent 8,129,343 against Hims & Hers regarding Semaglutide produc | [Link](https://longbridge.com/zh-CN/news/275312528.md) | | Hims & Hers Acquires Livewell to Launch Canadian Expansion | Hims & Hers Health Inc. has acquired Livewell, a Canadian digital health provider, to expand into the Canadian market. T | [Link](https://longbridge.com/zh-CN/news/268598929.md) | | SmartFinancial Inc. Chairman Wesley Miller Reports Acquisition of Common Shares | Wesley Miller Welborn, Chairman of SmartFinancial Inc., has reported the acquisition of common shares of the company. Th | [Link](https://longbridge.com/zh-CN/news/275517093.md) | | FormFactor Inc. Director Thomas St Dennis Sells Common Shares | Thomas St Dennis, Director at FormFactor Inc., has sold common shares of the company. The full filing is available throu | [Link](https://longbridge.com/zh-CN/news/275670858.md) | | Director Jorge Titinger Reports Sale of FormFactor Inc. Common Shares | Jorge Titinger, Director at FormFactor Inc., has reported the sale of common shares of the company. The full filing is a | [Link](https://longbridge.com/zh-CN/news/275519004.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。